Get Clarity. Check. Refer.
Learn about pulmonary arterial hypertension (PAH) and how you can play a part in earlier diagnosis to improve patient outcomes[1]
PAH is a severe, rare and progressive disease, which can lead to heart failure if left untreated.[2][3] Catching it early is crucial for your patients’ futures.[4]
This page is intended for healthcare providers. Are you a patient? Visit PH-human to find more information about PAH.
Learn more about PAH, including its clinical classification and various subtypes.
Find out about the different screening strategies used to identify PAH in at-risk patients.
Patients with suspected PAH should be referred to a specialist centre for further investigation.
Explore the investigative options to diagnose PAH.
PAH Congress
This year Janssen PAH will be attending several congresses. Take a look at what will be on offer here.
Useful resources
The 2015 European Society of Cardiology (ESC)/European Respiratory Society (ERS) pulmonary hypertension (PH) guidelines.
An overview of the 2018 World Symposium on Pulmonary Hypertension proceedings.
An easy-to-use educational app to help practitioners learn the echocardiographic signs of PH.
An easy-to-use educational app to help practitioners learn the echocardiographic signs of PH.
Start a conversation with one of our dedicated local representatives
Visit our dedicated local website.
ERS, European Respiratory Society; ESC, European Society of Cardiology; PAH, pulmonary arterial hypertension; PH, pulmonary hypertension; WSPH, World Symposium on Pulmonary Hypertension
